Webinar on now
questions i have put forwards
Have Anp had interaction with the FDA since the original meeting with reference to the tox issue ie are we any closer with regards to them accepting our 6 month trials in both animal studies and the succesful dmd trial and are we likely to hear from the upcoming Ann if this will be clarified in the minutes from the FDA with regards ANps plan to advance through the fda channels
Will ANP advise on the outcome of the pip or have you just moved straight into trial application without informing the market
Wilsons report reveals a $27mil spend for the EMA trial how are we going to fund this
Will ANP advise on the outcome of the pip or have you just moved straight into trial application without informing the market
Would ANP consider an IPO and listing on the NASDAQ to advance 1102 trial through the FDA route
Its early days yet regards the FDA but will ANP consider including Ambulant boys in the trials through the FDA, would appear to be a missed opportunity if you dont, considering these boys that are ambulant at some stage will have an increase in CD49d before becoming none ambulant
See what answers we get if any
See how we go
Chart, page-3633
-
-
- There are more pages in this discussion • 2,273 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.003(3.57%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.4¢ | 8.7¢ | 8.4¢ | $72.99K | 855.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 398595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 0.084 |
3 | 212500 | 0.083 |
2 | 106250 | 0.080 |
2 | 125578 | 0.079 |
1 | 12462 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 398595 | 1 |
0.088 | 400000 | 1 |
0.089 | 135000 | 2 |
0.090 | 794374 | 5 |
0.092 | 50000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online